PDS Biotechnology Corp Operating Lease, Liability, Current
PDS Biotechnology Corp (PDSB) had Operating Lease, Liability, Current of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2024-03-28
- 2023-12-31: Operating Lease, Liability, Current $0.00.
- 2023-09-30: Operating Lease, Liability, Current $0.00.
- 2023-06-30: Operating Lease, Liability, Current $59.65K.
- 2023-03-31: Operating Lease, Liability, Current $146.98K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $59.65K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $146.98K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $231.43K 10-K · filed 2024-03-28 |
| 2022-09-30 | $313.98K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $335.01K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $311.31K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $258.92K 10-K · filed 2023-03-28 |
| 2021-09-30 | $207.72K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $157.66K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $123.65K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $119.90K 10-K · filed 2022-03-31 |
| 2020-09-30 | $116.24K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $112.66K 10-Q · filed 2020-08-13 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-18 |
| 2019-06-30 | $492.09K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $477.30K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $0.00 10-Q · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |